tiprankstipranks
Fusion Antibodies Plc (GB:FAB)
LSE:FAB
UK Market

Fusion Antibodies Plc (FAB) Financial Statements

3 Followers

Fusion Antibodies Plc Financial Overview

Fusion Antibodies Plc's market cap is currently ―. The company's EPS TTM is p-0.086; its P/E ratio is -0.38; Fusion Antibodies Plc is scheduled to report earnings on December 4, 2023, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 1.20M£ 2.05M£ 1.99M£ 2.69M£ 3.24M
Total Assets£ 3.98M£ 4.92M£ 5.37M£ 5.83M£ 8.30M
Total Debt£ 333.00K£ 69.00K£ 152.00K£ 230.00K£ 309.00K
Net Debt£ -865.00K£ -1.98M£ -1.83M£ -2.46M£ -2.93M
Total Liabilities£ 1.41M£ 1.23M£ 1.13M£ 1.08M£ 936.00K
Stockholders Equity£ 2.57M£ 3.68M£ 4.25M£ 4.75M£ 7.37M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

Fusion Antibodies Plc Earnings and Revenue History

Fusion Antibodies Plc Debt to Assets

Fusion Antibodies Plc Cash Flow

Fusion Antibodies Plc Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis